Shop by goal
Popular compounds
Research resources
Recently viewed
Growth-Hormone Research Peptides
Growth-hormone secretagogue research compounds from both receptor classes studied in pituitary release models: GHRH analogues that act at the GHRH receptor, and ghrelin-receptor (GHS-R1a) agonists that act at a separate site. Half-life is the main practical difference within each class, from minutes to several days. Supplied for laboratory research only.
Best value per mg
Research Compounds
Create a Pack of Vials
Mix any eligible single vials into one pack of your own.
Tesamorelin
★★★★★ ★★★★★ 4.8 4 reviews
(Stabilised GHRH 1-44 Analog)
Stabilised GHRH(1-44) analogue studied for pituitary GH release and visceral adipose tissue endpoints in published research.
Ipamorelin
★★★★★ ★★★★★ 4 2 reviews
(Selective GH-Releasing Pentapeptide)
Selective ghrelin-receptor (GHS-R1a) agonist pentapeptide studied for GH-release selectivity relative to cortisol and prolactin in research models.
Sermorelin
(GHRH 1-29 / Growth Hormone-Releasing Factor)
GHRH(1-29) fragment studied for GHRH-receptor agonism and pulsatile pituitary GH release in endocrine research models.
CJC-1295 DAC
(Modified GRF 1-29 with Drug Affinity Complex)
Modified GRF(1-29) with a drug affinity complex for albumin binding, studied for extended GHRH-receptor signalling half-life in research.
Hexarelin
★★★★★ ★★★★★ 5 1 review
(Examorelin, MF-6003)
Synthetic GH-releasing hexapeptide studied for GHS-R1a and CD36 receptor binding, including cardiac endpoints, in research models.
CJC-1295 (no DAC)
(Modified GRF 1-29, Mod GRF)
Modified GRF(1-29) without a drug affinity complex, studied for short-acting GHRH-receptor agonism and pulsatile GH release in research.
GHRP-2
(Pralmorelin, KP-102)
Synthetic hexapeptide ghrelin-receptor agonist (pralmorelin) studied for GH secretion and related endocrine endpoints in research models.
GHRP-6
(Growth Hormone Releasing Hexapeptide)
Synthetic hexapeptide ghrelin-receptor agonist studied for GH secretion and appetite-signalling pathways in endocrine research models.
What you will find here
Sermorelin is GHRH(1-29). CJC-1295 without DAC (Mod GRF 1-29) carries four amino-acid substitutions, including D-Ala2 for DPP-IV resistance. CJC-1295 with DAC carries a Drug Affinity Complex that binds albumin, extending its half-life to roughly a week. Tesamorelin is a GHRH(1-44) analogue with an N-terminal hexenoic-acid group. On the ghrelin-receptor side, ipamorelin is studied as a selective GHS-R1a agonist. GHRP-2 and GHRP-6 are hexapeptide GHS-R1a agonists. Hexarelin, a related hexapeptide, also binds the CD36 receptor. Because the two classes act at different receptors, published models often pair one GHRH analogue with one ghrelin-receptor agonist, and each product page states the strengths available.
Research guides: GH-Axis Research
Added to cart
Explore New-U
Research tools and resources
Browse the catalogue, review the research library or use New-U’s free research tools.
Shop Research Peptides
Browse research peptides and compounds with clear variants, live pricing and batch documentation.
Guides & Blog
Read evidence-led compound guides, research comparisons, storage information and laboratory explainers.
Peptide Tracker
Open the calculator, protocol builder, calendar and half-life visualisation tools.
Peptide 101
Review the terminology, research context, handling fundamentals and quality-verification basics.
PRECISION. PURITY. PERFORMANCE.
Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.
Shop
Research
Support
Ways to Pay
Shop by goal
Shop by compound
Research use only - all claims made on this site are for testing and research use only. Purchasers must be 21 years of age or older.
All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.
Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.
Principal office: 1712 Pioneer Ave., Ste. 500, Cheyenne, WY 82001, USA
© 2026 New-U Research Compounds · new-u.io